Imperial College London
Alternate

DrSanjayPopat

Faculty of Medicine, National Heart & Lung Institute

Reader in Cancer Medicine
 
 
 
//

Contact

 

+44 (0)20 7808 2132s.popat Website

 
 
//

Location

 

Royal Marsden HospitalThe Royal Marsden Hospital

//

Summary

 

Publications

Citation

BibTex format

@article{Reckamp:2022:10.1080/03007995.2022.2100653,
author = {Reckamp, KL and Lin, HM and Cranmer, H and Wu, Y and Zhang, P and Kay, S and Walton, LJ and Shen, J and Popat, S and Camidge, DR},
doi = {10.1080/03007995.2022.2100653},
journal = {CURRENT MEDICAL RESEARCH AND OPINION},
pages = {1587--1593},
title = {Overall survival indirect treatment comparison between brigatinib and alectinib for the treatment of front-line anaplastic lymphoma kinase-positive non-small cell lung cancer using data from ALEX and final results from ALTA-1L},
url = {http://dx.doi.org/10.1080/03007995.2022.2100653},
volume = {38},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Reckamp,KL
AU  - Lin,HM
AU  - Cranmer,H
AU  - Wu,Y
AU  - Zhang,P
AU  - Kay,S
AU  - Walton,LJ
AU  - Shen,J
AU  - Popat,S
AU  - Camidge,DR
DO  - 10.1080/03007995.2022.2100653
EP  - 1593
PY  - 2022///
SN  - 0300-7995
SP  - 1587
TI  - Overall survival indirect treatment comparison between brigatinib and alectinib for the treatment of front-line anaplastic lymphoma kinase-positive non-small cell lung cancer using data from ALEX and final results from ALTA-1L
T2  - CURRENT MEDICAL RESEARCH AND OPINION
UR  - http://dx.doi.org/10.1080/03007995.2022.2100653
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000832909000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 38
ER  -
Download